Clinical Trial Update: A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C [Phase 1]

View source ↗

Summary

Phase 1 study of the investigational compound RO5428029 investigated in healthy volunteers and chronic hepatitis C patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• RO5428029

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic, Healthy Volunteer | Phase 1 | Status: COMPLETED